Lactobacillus gasseri BNR17
Commercial- Indications
- Weight management
Company intelligence / Profile preview
UAS Laboratories developed science-backed proprietary probiotic formulations based on well-researched strains like Lactobacillus acidophilus DDS®‑1. Their products are sold globally as finished goods or ingredients to private label customers. The company was recognized for high-quality standards in GMP-certified facilities. No clinical trial results typical of pharma/biotech drug development were reported; efficacy claims are based on published research about their key strains.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UAS Laboratories.